Sign up to save your podcasts
Or
Share High-Efficacy DMTs: Transforming MS Care
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
High-Efficacy DMTs: Transforming MS Care
CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/high-efficacy-dmts-transforming-ms-care/32225/
This series of bite-sized episodes contains important information on the use of high-efficacy disease-modifying therapies (DMTs) in multiple sclerosis (MS). Drs. Ahmed Obeidat and Mark Freedman discuss the role of inflammation in MS pathology, treatment strategies for high-efficacy DMTs, impact on cognition, and use in special populations.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.00
Valid until: 24-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/high-efficacy-dmts-transforming-ms-care/32225/
This series of bite-sized episodes contains important information on the use of high-efficacy disease-modifying therapies (DMTs) in multiple sclerosis (MS). Drs. Ahmed Obeidat and Mark Freedman discuss the role of inflammation in MS pathology, treatment strategies for high-efficacy DMTs, impact on cognition, and use in special populations.